BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6237815)

  • 1. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
    Bonomini V; Vangelista A; Frascà GM; Nanni-Costa A; Borgnino LC
    Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).
    Morimoto C
    Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum factors inhibiting cellular immunity in systemic lupus erythematosus].
    Lavalle C; Alcocer J; Gudiño J; Fraga A
    Prensa Med Mex; 1978; 43(1-2):16-20. PubMed ID: 309127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of C3 rosette formation by serum from patients with systemic lupus erythematosus. A corollary of disease activity.
    Scheinberg MA; Israel Filho G; Mendes NF; Vertzman L
    J Rheumatol; 1978; 5(1):19-25. PubMed ID: 305960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.
    Twomey JJ; Laughter AH; Steinberg AD
    J Clin Invest; 1978 Sep; 62(3):713-5. PubMed ID: 308514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocyte function and cell-mediated immunity in systemic lupus erythematosus.
    Landry M
    Arch Dermatol; 1977 Feb; 113(2):147-54. PubMed ID: 300001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
    Michalevicz R; Many A; Ramot B; Trainin N
    Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased circulating thymus-derived cells with receptors for the Fc portion of immunoglobulin G in systemic lupus erythematosus.
    Alarcón-Segovia D; Ruíz-Argüelles A
    J Clin Invest; 1978 Dec; 62(6):1390-4. PubMed ID: 311785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity (CMI) in psoriasis.
    Gliński W; Haftek M; Obałek S; Jabłońska S
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):755-60. PubMed ID: 312084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lymphocytotoxins of systemic lupus erythematosus (SLE) sera on T and B lymphocytes.
    Gergely P; Szegedi G; Szabó G; Fekete B; Petrányi G
    Acta Med Acad Sci Hung; 1975; 32(1):43-8. PubMed ID: 1086049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor and non-receptor-bearing lymphocytes in untreated systemic lupus erythematosus. Variations with disease activity.
    Díaz-Jouanen E; Rivero SJ; Llorente L; Alarcón-Segovia D
    Rev Invest Clin; 1977; 29(4):265-76. PubMed ID: 304591
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma.
    Horwitz DA; Garrett MA
    Clin Exp Immunol; 1977 Jan; 27(1):92-9. PubMed ID: 300308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T- and B-system immunity study of rheumatism patients].
    Petrov RV; Borisova AM; Abaskulieva EK; Cheredeev AN
    Vopr Revm; 1978; (2):16-22. PubMed ID: 307864
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of serum thymic hormone and of circulating T cells in rheumatoid arthritis and in systemic lupus erythematosus.
    Bach JF; Dardenne M; Clot J
    Rheumatology; 1975; 6():242-50. PubMed ID: 1081729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of complement-dependent lymphocyte rosette formation by sera of patients with chronic glomerulonephritis.
    Gluckman JC; Beaufils H; Sanchez F
    Clin Exp Immunol; 1976 Nov; 26(2):247-52. PubMed ID: 991456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppression in systemic lupus erythematosus. Effect of cyclophosphamide and corticoids on lymphocyte subpopulations].
    Fuks A; Carballal G; Manni JA
    Medicina (B Aires); 1979; 39(3):289-97. PubMed ID: 514050
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of prednisolone and azathioprine on T- and B-lymphocyte number in peripheral blood of patients with glomerulonephritis and systemic lupus erythematosus].
    Shilov EM; Tareeva IE; Gordovskaia NB
    Ter Arkh; 1978; 50(6):60-7. PubMed ID: 307828
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasmapheresis, an aid in the treatment of patients with active systematic lupus erythematosus?].
    Houwert DA; Kater L; Struyvenberg A
    Ned Tijdschr Geneeskd; 1978 May; 122(19):678-81. PubMed ID: 148592
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis of T-immunodeficiencies in lupus erythematosus and patient treatment with levamisole].
    Shaposhnikov OK; Gorbunov VF
    Vestn Dermatol Venerol; 1979 Mar; (3):3-6. PubMed ID: 311566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.